Daiichi Sankyo's small China acquisition should aid portfolio development
This article was originally published in Scrip
Executive Summary
Daiichi Sankyo has reached an agreement to acquire a small trading company in China in a move designed to ease the importation and sale of its products, including those from its Indian subsidiary Ranbaxy.